InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Scanlon Meghan, Vice-Présidente Senior, Présidente Urologie Santé Pelvique et Administratrice. Director active across 2 companies, notably Boston Scientific CORP. In total, 15 disclosures have been recorded. The latest transaction was disclosed on 1 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations15 total
02,062 shares0
Common Stock
SEC:0001225208-22-006331:0·
017,846 shares0
Common Stock
SEC:0001567619-22-008111:0·
01,019 shares0
Common Stock
SEC:0001225208-22-003868:0·
0779 shares0
Common Stock
SEC:0001225208-22-003088:0·
01,583 shares0
Common Stock
SEC:0001225208-22-002933:0·
01,108 shares0
Common Stock
SEC:0001225208-22-002699:0·
01,108 shares0
Common Stock
SEC:0001225208-22-002699·
€274,23213,850 shares@ €19.80020.0002% mcap53.5% of flow
Common Stock
SEC:0001225208-21-010901·
€274,23213,850 shares@ €19.80020.0002% mcap26.8% of flow
Common Stock
SEC:0001225208-21-010901:0·
0855 shares0
Common Stock
SEC:0001225208-21-010279·
0855 shares0
Common Stock
SEC:0001225208-21-010279:0·
€237,98816,450 shares@ €14.46730.0002% mcap46.5% of flow
Common Stock
SEC:0001225208-21-009606·
€237,98816,450 shares@ €14.46730.0002% mcap23.2% of flow
Common Stock
SEC:0001225208-21-009606:0·
02,061 shares0
Common Stock
SEC:0001225208-21-007475:0·
02,061 shares0
Common Stock
SEC:0001225208-21-007475·
15 of 15 declarations
About Scanlon Meghan
Meghan Scanlon is an executive at BOSTON SCIENTIFIC CORP.
